Please login to the form below

Grunenthal

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Grunenthal's 2013 immunology sales performance.

Graham Belgrave joins Cmed Clinical Sciences

He joins the UK-based firm from Grunenthal GmbH where he was senior vice president and global head of clinical development, science and operations.

Pharma deals in September 2015

It has received a positive EMA CHMP opinion and Grunenthal expects to launch Zalviso in the first half of 2016 and PDL expects to start to receive royalties thereafter. ... Specifically, PDL will receive 75% of the EU royalties under the Grunenthal

Grunenthal and AcelRx’s Zalviso approved in EU

delivery. AcelRx developed Zalviso and entered into a commercial collaboration with Grunenthal at the end of 2013. ... Grunenthal holds the rights for Zalviso in Europe and Australia while AcelRx retains all rights in North America.

Shire and Baxalta drugs among CHMP's latest recommendations

Grunenthal's Zalviso (sufentanil) for the treatment of post-operative pain. A hybrid medicine, Zalviso's application relied in part on the results of studies carried out with a reference product

Pharma deals in June 2015

Collaboration, options to acquire and license. 105. Boston Children's Hospital/ Proteus/ Grünenthal.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Featured jobs

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Senior Medical Writer: Salary TBC

Senior Medical Writer: Up to £50, 000 with Benefits

Account Director, Medical Education: Salary TBC

AD – Corporate Comms/ Public Affairs/ B2B – Healthcare Focus: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

Senior Planner – Healthcare Advertising – New Role: Salary TBC

Project/ Events Manager – Medical Education and Events Agency: Salary TBC

Account/ Project Director – Medical Affairs – Surrey: Salary TBC

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Project Manager/ Account Manager: Salary TBC

PR Director – Health & Wellbeing – Mat Cover (4 days a week)...: Salary TBC

Digital Account Director: Salary TBC

Senior Medical Writer: Great salary and benefits

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

International Childhood Cancer Day 2019: The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues: Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups: A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...